TGA approves Odefsey

30 August 2016 - The TGA has approved Gilead's combination product for HIV-1 infection Odefsey. ...

Read more →

TGA approves Descovy (emtricitabine with tenofovir alafenamide fumarate)

7 July 2016 - The TGA has approved Gilead Sciences' new dual combination product for patients with HIV infection. ...

Read more →

TGA publishes AusPAR for emtricitabine with elvitegravir and cobicistat and tenofovir alafenamide fumarate (Genvoya)

5 July 2016 - The TGA has published an AusPAR for Gilead's Genvoya. ...

Read more →

TGA approves Truvada for PrEP – next: put it on the PBS, say HIV advocates

6 May 2016 - Australians can now access HIV medication as a way of protecting themselves against HIV transmission. ...

Read more →